Eagle Global Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Eagle Global Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,510	Closed	-$229K	–	254
2020 Q4	$229K	Sell	1,510 -50	-3%	-$7.15K	0.02%	204
2020 Q3	$211K	Hold	1,560	–	–	0.02%	195
2020 Q2	$213K	Sell	1,560 -825	-35%	-$105K	0.02%	189
2020 Q1	$257K	Hold	2,385	–	–	0.03%	164
2019 Q4	$287K	Hold	2,385	–	–	0.01%	193
2019 Q3	$237K	Sell	2,385 -4,200	-64%	-$440K	0.01%	195
2019 Q2	$718K	Buy	6,585 +3,900	+145%	+$415K	0.03%	153
2019 Q1	$300K	Hold	2,685	–	–	0.01%	187
2018 Q4	$259K	Hold	2,685	–	–	0.01%	196
2018 Q3	$327K	Hold	2,685	–	–	0.01%	192
2018 Q2	$295K	Hold	2,685	–	–	0.01%	202
2018 Q1	$287K	Hold	2,685	–	–	0.01%	205
2017 Q4	$287K	Hold	2,685	–	–	0.01%	210
2017 Q3	$299K	Hold	2,685	–	–	0.01%	208
2017 Q2	$278K	Hold	2,685	–	–	0.01%	303
2017 Q1	$262K	Sell	2,685 -15,945	-86%	-$1.53M	0.01%	311
2016 Q4	$1.65M	Buy	+18,630	New	+$1.7M	0.05%	140

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Eagle Global Advisors's IBB Position: Q1 2021 in Review

Eagle Global Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 1,510 shares — an estimated $229K sold.

Eagle Global Advisors first reported a position in IBB in Q4 2016 and held it in 17 quarters. The position peaked at $1.65M in Q4 2016. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

Eagle Global Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
Eagle Global Advisors sold 1,510 iShares Biotechnology ETF shares in Q1 2021, an estimated $229K.
Eagle Global Advisors first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 17 quarters.
Eagle Global Advisors's iShares Biotechnology ETF position peaked at $1.65M in Q4 2016.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Eagle Global Advisors's 13F filing for Q1 2021, filed 7 May 2021.